,address1,address2,city,country,phone,fax,website,industry,sector,longBusinessSummary,fullTimeEmployees,companyOfficers,compensationAsOfEpochDate,maxAge,priceHint,previousClose,open,dayLow,dayHigh,regularMarketPreviousClose,regularMarketOpen,regularMarketDayLow,regularMarketDayHigh,payoutRatio,beta,volume,regularMarketVolume,averageVolume,averageVolume10days,averageDailyVolume10Day,bid,ask,bidSize,askSize,marketCap,fiftyTwoWeekLow,fiftyTwoWeekHigh,fiftyDayAverage,twoHundredDayAverage,trailingAnnualDividendRate,trailingAnnualDividendYield,currency,enterpriseValue,profitMargins,floatShares,sharesOutstanding,sharesShort,sharesShortPriorMonth,sharesShortPreviousMonthDate,dateShortInterest,sharesPercentSharesOut,heldPercentInsiders,heldPercentInstitutions,shortRatio,shortPercentOfFloat,bookValue,priceToBook,lastFiscalYearEnd,nextFiscalYearEnd,mostRecentQuarter,netIncomeToCommon,trailingEps,enterpriseToEbitda,exchange,quoteType,symbol,underlyingSymbol,shortName,longName,firstTradeDateEpochUtc,timeZoneFullName,timeZoneShortName,gmtOffSetMilliseconds,currentPrice,recommendationKey,ebitda,totalDebt,returnOnAssets,returnOnEquity,grossMargins,ebitdaMargins,operatingMargins,financialCurrency,trailingPegRatio
0,First Commercial Building,11th Floor 33-35 Leighton Road,Causeway Bay,Hong Kong,852 2155 0823,852 2155 0853,https://www.regencellbioscience.com,Drug Manufacturers—Specialty & Generic,Healthcare,"Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.",13,"{'maxAge': 1, 'name': 'Mr. Yat-Gai  Au', 'age': 49, 'title': 'Founder, Chairman & CEO', 'yearBorn': 1973, 'fiscalYear': 2022, 'totalPay': 0, 'exercisedValue': 0, 'unexercisedValue': 0}",1672444800,86400,2,12.23,12.41,11.82,12.8,12.23,12.41,11.82,12.8,0.0,0.302068,1404,1404,1570,1260,1260,4.96,12.8,900,900,163565648,10.7,34.0,16.85668,24.35395,0.0,0.0,USD,163565216,0.0,1462386,13012900,668,381,1690761600,1693440000,0.0001,0.88762003,6.0000002e-05,0.29,0.00029999999,1.128,11.143173,1656547200,1688083200,1672444800,-7081869,-0.46,-22.792,NCM,EQUITY,RGC,RGC,Regencell Bioscience Holdings L,Regencell Bioscience Holdings Limited,1626442200,America/New_York,EDT,-14400000,12.5695,none,-7176390,0,-0.25226,-0.42189,0.0,0.0,0.0,USD,
1,First Commercial Building,11th Floor 33-35 Leighton Road,Causeway Bay,Hong Kong,852 2155 0823,852 2155 0853,https://www.regencellbioscience.com,Drug Manufacturers—Specialty & Generic,Healthcare,"Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.",13,"{'maxAge': 1, 'name': 'Ms. Michelle  Chan', 'title': 'Financial Controller', 'exercisedValue': 0, 'unexercisedValue': 0}",1672444800,86400,2,12.23,12.41,11.82,12.8,12.23,12.41,11.82,12.8,0.0,0.302068,1404,1404,1570,1260,1260,4.96,12.8,900,900,163565648,10.7,34.0,16.85668,24.35395,0.0,0.0,USD,163565216,0.0,1462386,13012900,668,381,1690761600,1693440000,0.0001,0.88762003,6.0000002e-05,0.29,0.00029999999,1.128,11.143173,1656547200,1688083200,1672444800,-7081869,-0.46,-22.792,NCM,EQUITY,RGC,RGC,Regencell Bioscience Holdings L,Regencell Bioscience Holdings Limited,1626442200,America/New_York,EDT,-14400000,12.5695,none,-7176390,0,-0.25226,-0.42189,0.0,0.0,0.0,USD,
2,First Commercial Building,11th Floor 33-35 Leighton Road,Causeway Bay,Hong Kong,852 2155 0823,852 2155 0853,https://www.regencellbioscience.com,Drug Manufacturers—Specialty & Generic,Healthcare,"Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.",13,"{'maxAge': 1, 'name': 'Mr. Wai Hong  Chung', 'age': 45, 'title': 'COO & Chief Strategy Officer', 'yearBorn': 1977, 'fiscalYear': 2021, 'exercisedValue': 0, 'unexercisedValue': 0}",1672444800,86400,2,12.23,12.41,11.82,12.8,12.23,12.41,11.82,12.8,0.0,0.302068,1404,1404,1570,1260,1260,4.96,12.8,900,900,163565648,10.7,34.0,16.85668,24.35395,0.0,0.0,USD,163565216,0.0,1462386,13012900,668,381,1690761600,1693440000,0.0001,0.88762003,6.0000002e-05,0.29,0.00029999999,1.128,11.143173,1656547200,1688083200,1672444800,-7081869,-0.46,-22.792,NCM,EQUITY,RGC,RGC,Regencell Bioscience Holdings L,Regencell Bioscience Holdings Limited,1626442200,America/New_York,EDT,-14400000,12.5695,none,-7176390,0,-0.25226,-0.42189,0.0,0.0,0.0,USD,
3,First Commercial Building,11th Floor 33-35 Leighton Road,Causeway Bay,Hong Kong,852 2155 0823,852 2155 0853,https://www.regencellbioscience.com,Drug Manufacturers—Specialty & Generic,Healthcare,"Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.",13,"{'maxAge': 1, 'name': 'Mr. Tien Hsiang  Chau', 'age': 52, 'title': 'Exec. Officer', 'yearBorn': 1970, 'fiscalYear': 2021, 'exercisedValue': 0, 'unexercisedValue': 0}",1672444800,86400,2,12.23,12.41,11.82,12.8,12.23,12.41,11.82,12.8,0.0,0.302068,1404,1404,1570,1260,1260,4.96,12.8,900,900,163565648,10.7,34.0,16.85668,24.35395,0.0,0.0,USD,163565216,0.0,1462386,13012900,668,381,1690761600,1693440000,0.0001,0.88762003,6.0000002e-05,0.29,0.00029999999,1.128,11.143173,1656547200,1688083200,1672444800,-7081869,-0.46,-22.792,NCM,EQUITY,RGC,RGC,Regencell Bioscience Holdings L,Regencell Bioscience Holdings Limited,1626442200,America/New_York,EDT,-14400000,12.5695,none,-7176390,0,-0.25226,-0.42189,0.0,0.0,0.0,USD,
4,First Commercial Building,11th Floor 33-35 Leighton Road,Causeway Bay,Hong Kong,852 2155 0823,852 2155 0853,https://www.regencellbioscience.com,Drug Manufacturers—Specialty & Generic,Healthcare,"Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.",13,"{'maxAge': 1, 'name': 'Ms. Antonia  Assang', 'title': 'Sr. VP of Project Management', 'exercisedValue': 0, 'unexercisedValue': 0}",1672444800,86400,2,12.23,12.41,11.82,12.8,12.23,12.41,11.82,12.8,0.0,0.302068,1404,1404,1570,1260,1260,4.96,12.8,900,900,163565648,10.7,34.0,16.85668,24.35395,0.0,0.0,USD,163565216,0.0,1462386,13012900,668,381,1690761600,1693440000,0.0001,0.88762003,6.0000002e-05,0.29,0.00029999999,1.128,11.143173,1656547200,1688083200,1672444800,-7081869,-0.46,-22.792,NCM,EQUITY,RGC,RGC,Regencell Bioscience Holdings L,Regencell Bioscience Holdings Limited,1626442200,America/New_York,EDT,-14400000,12.5695,none,-7176390,0,-0.25226,-0.42189,0.0,0.0,0.0,USD,
5,First Commercial Building,11th Floor 33-35 Leighton Road,Causeway Bay,Hong Kong,852 2155 0823,852 2155 0853,https://www.regencellbioscience.com,Drug Manufacturers—Specialty & Generic,Healthcare,"Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.",13,"{'maxAge': 1, 'name': 'Mr. Yat-Pui  Au', 'title': 'Chief Bus. Officer', 'exercisedValue': 0, 'unexercisedValue': 0}",1672444800,86400,2,12.23,12.41,11.82,12.8,12.23,12.41,11.82,12.8,0.0,0.302068,1404,1404,1570,1260,1260,4.96,12.8,900,900,163565648,10.7,34.0,16.85668,24.35395,0.0,0.0,USD,163565216,0.0,1462386,13012900,668,381,1690761600,1693440000,0.0001,0.88762003,6.0000002e-05,0.29,0.00029999999,1.128,11.143173,1656547200,1688083200,1672444800,-7081869,-0.46,-22.792,NCM,EQUITY,RGC,RGC,Regencell Bioscience Holdings L,Regencell Bioscience Holdings Limited,1626442200,America/New_York,EDT,-14400000,12.5695,none,-7176390,0,-0.25226,-0.42189,0.0,0.0,0.0,USD,
